Who owns KALA PHARMACEUTICALS INC?
- Ticker: KALA
- CUSIP Number: 483119202
Tip: Access positions for across all investors
Analyze quarterly positions in Kala Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kala Pharmaceuticals stock
Who bought or sold KALA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 282k | $49k | 400% | Mar 2026 |
|
| Geode Capital Management | 261k | $45k | 327% | Mar 2026 |
|
| ADAR1 Capital Management | 142k | $25k | 0% | Mar 2026 |
|
| Vanguard Group | 91k | $51k | -57% | Dec 2025 |
|
| Virtu Financial | 86k | $48k | 100% | Dec 2025 |
|
| GSA Capital Partners | 85k | $15k | 100% | Mar 2026 |
|
| UBS Group | 67k | $12k | 180% | Mar 2026 |
|
| Vanguard Capital Management | 61k | $11k | 100% | Mar 2026 |
|
| Renaissance Technologies | 41k | $23k | 100% | Dec 2025 |
|
| Jane Street | 36k | $6.2k | -75% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 30k | $5.1k | 100% | Mar 2026 |
|
| State Street Corporation | 29k | $16k | 0% | Dec 2025 |
|
| XTX Topco | 28k | $16k | 100% | Dec 2025 |
|
| Grant Private Wealth Management | 20k | $3.5k | 100% | Mar 2026 |
|
| Greenwich Wealth Management | 18k | $3.0k | 100% | Mar 2026 |
|
| LPL Financial | 17k | $3.0k | 100% | Mar 2026 |
|
| Goldman Sachs Group | 14k | $2.4k | 100% | Mar 2026 |
|
| Intl Fcstone | 13k | $2.2k | 6% | Mar 2026 |
|
| Northern Trust | 12k | $6.4k | 0% | Dec 2025 |
|
| BlackRock | 11k | $1.9k | -50% | Mar 2026 |
|
| Morgan Stanley | 2.9k | $508.498900 | 385% | Mar 2026 |
|
| Covestor | 1.3k | $0 | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 832.00 | $144.019200 | 100% | Mar 2026 |
|
| MAI Wealth Advisors | 300.00 | $51.990000 | 0% | Mar 2026 |
|
| Steward Partners Investment Advisory | 120.00 | $21.000000 | 0% | Mar 2026 |
|
| International Assets Investment Management | 110.00 | $17.996000 | 0% | Mar 2026 |
|
| Legacy Wealth Managment | 25.00 | $5.000000 | 0% | Mar 2026 |
|
| SBI Securities | 8.00 | $1.000000 | 0% | Mar 2026 |
|
| Motiv8 Investments | 2.00 | $0 | 100% | Dec 2025 |
|
Who sold out of Kala Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Baker Bros. Advisors | Dec 2025 | 1.8M | $1.0M |
| Woodline Partners | Dec 2025 | 224k | $125k |
| Two Sigma Investments | Dec 2025 | 27k | $15k |
| Two Sigma Securities | Dec 2025 | 13k | $7.3k |
| SG Americas Securities | Dec 2025 | 10k | $6.0k |
| Tower Research Capital | Sep 2025 | 5.1k | $7.8k |
| Jpmorgan Chase & Co | Sep 2025 | 51.00 | $77.713800 |